• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

IMS Health

Anonymous board for IMS Health.
Replies
6
Views
4K
Anonymous
Replies
20
Views
12K
Anonymous
Replies
0
Views
3K
Anonymous
Replies
3
Views
4K
Anonymous
Replies
8
Views
4K
Anonymous
Replies
12
Views
4K
Anonymous
Replies
67
Views
18K
Anonymous